Cargando…
Combination of bevacizumab and bromfenac therapy in age-related macular degeneration: A pilot study
BACKGROUND: According to recent studies, the newest strategy for the treatment of exudative age-related macular degeneration is to combine anti-VEGF agents with non-steroid anti-inflammatory drugs (NSAIDs) such as nepafenac and bromfenac to decrease the frequency of intravitreal injections. Since mo...
Autores principales: | Wyględowska-Promieńska, Dorota, Piotrowska-Gwóźdź, Anna, Piotrowska-Seweryn, Agnieszka, Mazur-Piotrowska, Grażyna, Rokicki, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102605/ https://www.ncbi.nlm.nih.gov/pubmed/25006692 http://dx.doi.org/10.12659/MSM.890671 |
Ejemplares similares
-
Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD
por: Wyględowska-Promieńska, Dorota, et al.
Publicado: (2015) -
Different Impacts of Luminosity on Contrast Vision in Eyes with Transparent Optic Media and with Cataract Simulation
por: Smedowski, Adrian, et al.
Publicado: (2015) -
Inducible and Endothelial Nitric Synthetase Expression and Nitrotyrosine Accumulation in Iris Vasculature of Patients with Primary Open-Angle Glaucoma: A Pilot Study
por: Rokicki, Wojciech, et al.
Publicado: (2015) -
Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: A pilot study
por: Du, Qing-Wei, et al.
Publicado: (2013) -
Brolucizumab for macular degeneration
Publicado: (2020)